EUVIMEDEUVIMED entdecken
Crossref

Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”

Marketa Marvanova

The Senior Care Pharmacist · 01.08.2026 · 41 (5) · 157-158

DOI: 10.4140/tcp.n.2026.157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Senior Care Pharmacist, erschienen am 01.08.2026. Verfasst von Marketa Marvanova. Beteiligte Einrichtung: Dean and Professor, Pacific University School of Pharmacy. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Dean and Professor, Pacific University School of Pharmacy.

Zitieren

APA

Marvanova, M. (2026). Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”. The Senior Care Pharmacist, 41(5), 157-158. https://doi.org/10.4140/tcp.n.2026.157

Vancouver

Marvanova M. Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”. The Senior Care Pharmacist. 2026;41(5):157-158. doi:10.4140/tcp.n.2026.157

BibTeX
@article{Marvanova2026,
  author = {Marvanova, Marketa},
  title = {Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”},
  journal = {The Senior Care Pharmacist},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {157--158},
  doi = {10.4140/tcp.n.2026.157}
}
Kostenlos starten →